$10.030
-1.016 (-10.13%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
TLX 相似圖表分析預測
Alphio's TLX stock price prediction model matches the current Telix Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.66 (-3.64%). The 1-week path is $9.74 (-2.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Telix Pharmaceuticals Ltd 股票嗎？
Telix Pharmaceuticals is currently not a strong buy due to its low RSI of 39.41, indicating oversold conditions, and a forward P/E ratio of 140.85, suggesting overvaluation. However, the recent FDA approval of Pixclara and the acquisition of ITM for $2.35 billion could drive future growth. The main risk is the high forward P/E, which reflects market skepticism about future earnings growth.
TLX 股價於 Wednesday 收在 $10.03，此前下跌 -10.13%
Telix Pharmaceuticals Ltd (TLX) last closed at $10.03, losing -10.13%. These facts feed the 1-day and 1-week TLX price prediction above.
預測驅動因素
Telix Pharmaceuticals Ltd（TLX）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 TLX 最接近的股票，依相似度排序。
TLX 季節性分析
Historically the probability of a positive October return for TLX is 39.47%. May offers the highest probability of a positive month at 100.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。